Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Hemogenyx Pharmaceuticals PLC
Hemogenyx Pharmaceuticals PLC Announces New Custom R&D Facility Opening
July 13, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Investor Webinar Recording
July 08, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Change of Registered Office
July 01, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
June 30, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Investor Webinar
June 27, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM
June 07, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding
May 30, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Immuno-Oncology Summit Europe Presentation
May 16, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC announces Final Results for the Year Ended 31 December 2021
April 29, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces CBR Update
March 16, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T pre-IND Meeting Request
February 16, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
COVID-19
Product Safety
Hemogenyx Pharmaceuticals Partnership with Selexis
January 12, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces H.C. Wainwright Bioconnect Conference
January 05, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Hemo-CAR-T partnership with WuXi ATU
December 20, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T pre-IND Meeting Request
December 13, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
Product Safety
Hemogenyx Pharmaceuticals PLC Announces Convertible Loans Repayment
November 24, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Lease of New York Mink Building Custom Laboratory
October 18, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals Announces CDX Licence Agreement
October 13, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Half-Year Report
September 30, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces U.S. Approval of Monoclonal Antibody Patent
September 02, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Appointment of Business Advisor & Board Observer
July 26, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC announces Corporate Presentation
July 02, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
June 25, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Changes to 2021 AGM Arrangements
June 15, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
COVID-19
Hemogenyx Pharmaceuticals PLC Announces
June 02, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM
May 28, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
COVID-19
Hemogenyx Pharmaceuticals PLC announces Total Voting Rights
May 28, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Termination of Mint Facility; Admission of Shares
May 26, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding
May 19, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Loan Notes Sale & Conversion; Facility Terminated
May 18, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.